Milestone Pharmaceuticals
MIST
MIST
78 hedge funds and large institutions have $53.6M invested in Milestone Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9.06% less ownership
Funds ownership: 40.17% → 31.11% (-9.1%)
22% less capital invested
Capital invested by funds: $68.3M → $53.6M (-$14.7M)
73% less call options, than puts
Call options by funds: $667K | Put options by funds: $2.47M
Holders
78
Holding in Top 10
2
Calls
$667K
Puts
$2.47M
Top Buyers
| 1 | +$2.65M | |
| 2 | +$1.83M | |
| 3 | +$1.47M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.43M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.04M |
Top Sellers
| 1 | -$8.97M | |
| 2 | -$6.44M | |
| 3 | -$4.71M | |
| 4 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
-$2.86M |
| 5 |
PBM
Propel Bio Management
Los Angeles,
California
|
-$2.17M |
